Post-approval studies (Phase 4)Study completedNCT00672477
What this trial is testing
Study Evaluating Subcutaneous Methylnaltrexone For Treatment Of Opioid-Induced Constipation In Patients With Advanced Illness
Who this might be right for
Opioid-Induced Constipation
Bausch Health Americas, Inc. 237